Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. Summary
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
Delayed NSE India Stock Exchange  -  07:25 2022-09-23 am EDT
921.10 INR   +1.44%
09/23Indian Benchmarks Drop Nearly 2%; Power Grid Corp. of India Slumps 8%
MT
08/19SUN PHARMACEUTICAL INDUSTRIES LTD. : Ex-dividend day for final dividend
FA
08/18Indian shares drift lower as global mood dour after Fed minutes
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
09/19/2022 09/20/2022 09/21/2022 09/22/2022 09/23/2022 Date
874.85(c) 911.95(c) 905.3(c) 908(c) 921.1(c) Last
1 920 725 4 408 042 4 153 228 2 317 690 4 802 181 Volume
+0.78% +4.24% -0.73% +0.30% +1.44% Change
More quotes
Estimated financial data (e)
Sales 2023 434 B 5 348 M 5 348 M
Net income 2023 84 019 M 1 036 M 1 036 M
Net cash position 2023 117 B 1 438 M 1 438 M
P/E ratio 2023 26,3x
Yield 2023 0,84%
Sales 2024 482 B 5 943 M 5 943 M
Net income 2024 98 699 M 1 217 M 1 217 M
Net cash position 2024 167 B 2 053 M 2 053 M
P/E ratio 2024 22,4x
Yield 2024 0,95%
Capitalization 2 210 B 27 243 M 27 243 M
EV / Sales 2023 4,83x
EV / Sales 2024 4,24x
Nbr of Employees 38 000
Free-Float 44,4%
More Financials
Company
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants... 
Sector
Pharmaceuticals
Calendar
11/15Earnings Release
More about the company
Ratings of Sun Pharmaceutical Industries Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
09/23Indian Benchmarks Drop Nearly 2%; Power Grid Corp. of India Slumps 8%
MT
08/19SUN PHARMACEUTICAL INDUSTRIES LTD. : Ex-dividend day for final dividend
FA
08/18Indian shares drift lower as global mood dour after Fed minutes
RE
08/17GSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
MT
08/16Plaintiff in first Zantac lawsuit set for trial drops case
RE
08/15Sun Pharmaceutical Industries Gets OAI from US FDA for Manufacturing Facility in Halol,..
MT
08/03Indian Indices Settle in Green Midweek; Maruti Suzuki India Tops Losers
MT
08/02Sun Pharmaceutical Industries Chairman to Retire
MT
08/02Sun Pharmaceutical Industries Limited Announces Retirement of Israel Makov as Chairman ..
CI
08/02Sun Pharmaceutical Industries Limited Recommends Final Dividend for the Year 2021-22, P..
CI
08/01Indian Indices Close on Positive Note on Monday; Tata Motors Jumps 7%
MT
07/29TRANSCRIPT : Sun Pharmaceutical Industries Limited, Q1 2023 Earnings Call, Jul 29, 2022
CI
07/29Sun Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter En..
CI
07/29India's Nifty posts best month since November 2020, rupee surges
RE
07/27Indian shares rise as Bajaj Finance, L&T jump on strong results
RE
More news
News in other languages on SUN PHARMACEUTICAL INDUSTRIES LTD.
08/29SUN PHARMACEUTICAL INDUSTRIES : Newspaper Advertisements
08/17GSK déclare qu'aucun paiement n'a été effectué après que le plaignant du Zantac ait aba..
08/15Sun Pharmaceutical Industries obtient l'OAI de la FDA américaine pour son usine de fabr..
08/03Les indices indiens s'installent dans le vert en milieu de semaine ; Maruti Suzuki Indi..
08/02Le président de Sun Pharmaceutical Industries prend sa retraite
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
ETFs positioned on SUN PHARMACEUTICAL INDUSTRIES LTD.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
VanEck Vectors India Growth Leaders ETF - USD5.68%-3.49%-India
Franklin FTSE India ETF Dist - USD1.22%-3.45%India
IShares MSCI India Accumulating - USD1.22%-3.32%India
IShares MSCI India ETF - USD1.06%-3.59%India
IShares MSCI EM Islamic - USD0.63%-2.49%World
More ETFs positioned on SUN PHARMACEUTICAL INDUSTRIES LTD.
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 38
Last Close Price 921,10 INR
Average target price 1 069,58 INR
Spread / Average Target 16,1%
EPS Revisions
Managers and Directors
Dilip Shantilal Shanghvi Managing Director & Executive Director
C. S. Muralidharan Chief Financial Officer
Atanu Roy SVP & Chief Information Officer
Davinder Singh Executive Vice President-Global Operations
Ashok I. Bhuta Compliance Officer & Senior GM-Secretarial